Page 267 - Read Online

Mondal et al. Neuroimmunol Neuroinflammation 2018;5:34 I http://dx.doi.org/10.20517/2347-8659.2018.13 Page 19 of 19

associated cytokines TNF-alpha, VEGF and apoptotoic protein Bax, Bcl2 abrogates tumor cells. Cell Immunol 2013;284:172-81.
64. Bhattacharjee M, Acharya S, Ghosh A, Sarkar P, Chatterjee S, Kumar P, Chaudhuri S. Bax and Bid act in synergy to bring about
T11TS-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation. Int Immunol
2008;20:1489-505.
65. Bhattacharya D, Singh MK, Chaudhuri S, Datta A, Chaudhuri S. T11TS treatment augments apoptosis of glioma associated brain
endothelial cells, hint toward anti-angiogenic action in glioma. J Cell Physiol 2017;232:526-39.
66. Mukherjee J, Sarkar S, Ghosh A, Duttagupta AK, Chaudhuri S, Chaudhuri S. Immunotherapeutic effects of T11TS/S-LFA3 against
nitrosocompound mediated neural genotoxicity. Toxicol Lett 2004;150:239-57.
67. Begum Z, Ghosh A, Sarkar S, Mukherjee J, Mazumdar M, Sarkar P, Chaudhuri S. Documentation of immune profile of microglia
through cell surface marker study in glioma model primed by a novel cell surface glycopeptide T11TS/SLFA-3. Glycoconj J
2003;20:515-23.
68. Stella CC, Cazzola M, De FP, De VA, Gianni AM, Lanza F, Lauria F, Lemoli RM, Tarella C, Zanon P. CD34-positive cells: biology and
clinical relevance. Haematologica 1995;80:367-87.
69. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development
1990;110:1001-20.
70. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative
hematopoietic stem cell. Science 1996;273:242-5.
71. Holmes C, Stanford WL. Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells 2007;25:1339-47.
72. Walasek MA, Bystrykh LV, Olthof S, de HG, van OR. Sca-1 is an early-response target of histone deacetylase inhibitors and marks
hematopoietic cells with enhanced function. Exp Hematol 2013;41:113-23.
73. Harman BC, Northrup DL, Allman D. Resolution of unique Sca-1highc-Kit- lymphoid-biased progenitors in adult bone marrow. J
Immunol 2008;181:7514-24.
74. Orschell-Traycoff CM, Hiatt K, Dagher RN, Rice S, Yoder MC, Srour EF. Homing and engraftment potential of Sca-1(+)lin(-) cells
fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood 2000;96:1380-7.
75. Simmons PJ, Aylett GW, Niutta S, To LB, Juttner CA, Ashman LK. C-kit is expressed by primitive human hematopoietic cells that give
rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. Exp Hematol 1994;22:157-65.
76. Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S, Kunisada T, Sudo T, Kina T, Nakauchi H, Nishikawa S. Expression and function of c-kit
in hemopoietic progenitor cells. J Exp Med 1991;174:63-71.
77. Katayama N, Clark SC, Ogawa M. Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic
progenitors. Blood 1993;81:610-6.
78. Okada S, Nakauchi H, Nagayoshi K, Nishikawa S, Nishikawa S, Miura Y, Suda T. Enrichment and characterization of murine
hematopoietic stem cells that express c-kit molecule. Blood 1991;78:1706-12.
79. Henrich CJ, Goncharova EI, Wilson JA, Gardella RS, Johnson TR, McMahon JB, Takada K, Bokesch HR, Gustafson KR. Natural
products active in aberrant c-Kit signaling. Chem Biol Drug Des 2007;69:321-30.
80. Lian Z, Toki J, Yu C, Hayashi H, Yasumizu R, Sugiura K, Jin T, Inaba M, Hisha H, Li Y, Yu W, Fan H, Ikehara S. Intrathymically
injected hemopoietic stem cells can differentiate into all lineage cells in the thymus: differences between c-kit+ cells and c-kit < low
cells. Stem Cells 1997;15:430-6.
81. Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations.
Annu Rev Cell Dev Biol 2001;17:387-403.
82. Morrison SJ, Wright DE, Weissman IL. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to
proliferate prior to mobilization. Proc Natl Acad Sci U S A 1997;94:1908-13.
83. Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000;100:157-68.
84. Arai F, Hirao A, Suda T. Regulation of hematopoietic stem cells by the niche. Trends Cardiovasc Med 2005;15:75-9.
85. Arai F, Suda T. Quiescent stem cells in the niche. Cambridge (MA): Harvard Stem Cell Institute; 2008.
86. Bhattacharya D, Chaudhuri S, Singh MK, Chaudhuri S. T11TS inhibits Angiopoietin-1/Tie-2 signaling, EGFR activation and Raf/MEK/
ERK pathway in brain endothelial cells restraining angiogenesis in glioma model. Exp Mol Pathol 2015;98:455-66.
87. Gomei Y, Nakamura Y, Yoshihara H, Hosokawa K, Iwasaki H, Suda T, Arai F. Functional differences between two Tie2 ligands,
Angiopoietin-1 and -2, in regulation of adult bone marrow hematopoietic stem cells. Exp Hematol 2010;38:82-9.